A class action lawsuit has been filed against Amylyx Pharmaceuticals ( NASDAQ:AMLX ) on February 9, 2024. The plaintiffs (shareholders) allege that they bought Amylyx stock at artificially inflated prices between November 11, 2022 and November 8, 2023 (Class Period) and are now seeking compensation for the damages. Investors who bought AMLX stock during that period can learn about joining the lawsuit here: https://zlk.com/pslra-1/amylyx-lawsuit-submission-form?wire=16 Amylyx is a clinical-stage pharmaceutical company focused on developing potential treatments for neurodegenerative diseases.